Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000220043 | SCV000276900 | likely benign | Hereditary cancer-predisposing syndrome | 2014-11-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000640419 | SCV000762010 | likely benign | Familial adenomatous polyposis 2 | 2023-10-23 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000220043 | SCV004358553 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-02 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000640419 | SCV004835544 | likely benign | Familial adenomatous polyposis 2 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV004596124 | SCV005090565 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing |